4
Changes in Ownership
CRISPR Therapeutics AG Filed Acc 0000899243-18-012101
Director sold 121,362 shares at an average $50.39 ($6,115,873)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Woiwode Thomas Director | 2018-05-07 | Sale | −97,550 | $50.31 | $4,907,741 | 1,199,784 | I |
| Woiwode Thomas Director | 2018-05-07 | Sale | −2,862 | $50.31 | $143,987 | 35,202 | I |
| Woiwode Thomas Director | 2018-05-07 | Sale | −3,172 | $50.31 | $159,583 | 39,021 | I |
| Woiwode Thomas Director | 2018-05-07 | Sale | −7,424 | $50.31 | $373,501 | 91,312 | I |
| Woiwode Thomas Director | 2018-05-07 | Sale | −7,645 | $51.26 | $391,883 | 1,192,139 | I |
| Woiwode Thomas Director | 2018-05-07 | Sale | −225 | $51.26 | $11,534 | 34,977 | I |
| Woiwode Thomas Director | 2018-05-07 | Sale | −249 | $51.26 | $12,764 | 38,772 | I |
| Woiwode Thomas Director | 2018-05-07 | Sale | −582 | $51.26 | $29,833 | 90,730 | I |
| Woiwode Thomas Director | 2018-05-08 | Sale | −1,653 | $51.45 | $85,047 | 5,629 | D |
| Open-market sales · 121,362 sh · avg $50.39 · $6,115,873 | |||||||
Loading xslF345X03/doc4.xml…